In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis

Human Immunology

Volumn 71, Issue 11, 2010, Pages 1099-1104

  Giampietro, Francesca ^a   de Waard, Jacobus H ^a   Rivas Santiago, Bruno ^b   Enciso Moreno, José Antonio ^b   Salgado, Antonio ^a   Araujo, Zaida ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

IL; PBMCs; PPD; TB

Indexed keywords

INTERLEUKIN 12P40; INTERLEUKIN 14; INTERLEUKIN 5; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL;

ADULT; CELL PROLIFERATION; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION GROUPS; PREVALENCE; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; TUBERCULIN; TUBERCULOSIS, PULMONARY; VENEZUELA;

EID: 77957756279     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.07.006     Document Type: Article

References (32)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. JAMA 1999, 282:677-686. WHO global surveillance and monitoring project.
2. Flynn J., Chan J. Immunology of tuberculosis. Annu Rev Immunol 2000, 9:93-129.
3. Rivas-Santiago B., Vieyra-Reyes P., Araujo Z. The cellular immune response in pulmonary tuberculosis. Invest Clin 2005, 46:391-412.
4. Strieter R.M., Belperio J.A., Keane M.P. Cytokines in innate host defense in the lung. J Clin Invest 2002, 109:699-705.
5. Wang Y., Curry H.M., Zwilling B.S., Lafuse W.P. Mycobacteria inhibition of IFN-{gamma} induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J Immunol 2005, 9:5687-5694.
6. Sahiratmadja E., Alisjahbana B., de Boer T., Adnan I., Maya A., Danusantoso H., et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007, 75:820-829.
7. Skamene E. Genetic control of host resistance to mycobacterial infection. Curr Top Microbiol Immunol 1986, 124:49-66.
8. Layrisse Z., Heinen H.D., Balbas O., García E., Stoikow Z. Unique HLA-DR/DQ associations revealed by family studies in Warao Amerindians. Haplotype and homozygosity frequencies. Hum Immunol 1988, 23:45-57.
9. Makhatadze N.J., Franco M.T., Layrisse Z. HLA class I and class II allele and haplotype distribution in the Venezuelan population. Hum Immunol 1997, 55:53-58.
10. SeminarIo Técnico-Administrativo 2002, Ministerio de Salud y Desarrollo Social (MSDS), Programa integrado de control de la tuberculosis, Caracas, Venezuela.
11. Fernández de Larrea C., Fandiño C., López D., del Nogal B., Rodríguez N., Convit J. Childhood tuberculosis in the Warao population in Venezuela. Invest Clin 2002, 43:35-48.
12. Arnadottir T., Rieder H.I., Trebuq A., Waaler A. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Int J Tuberc Lung Dis 1996, 77:1-20.
13. Kudoh S., Kudoh T. A simple technique for culturing tubercle bacilli. Bull World Health Organ 1974, 51:71-82.
14. Hussain R., Talat N., Shahid F., Dawood G. Longitudinal tracking of cytokines after acute exposure to tuberculosis: Association of distinct cytokine patters with protection and disease development. Clin Vaccine Immunol 2007, 14:1578-1586.
15. Almeida A., Lago P.M., Boechat N., Huard R.C., Lazzarini L.C.O., Santos A.R., mHuang J., Gibson A.L., Flores V.C., Pecanha L.R., Kritski A.L., Lapa e Silva J.R., Ho J.L., et al. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol 2009, 183:718-731.
16. Zhuang Y., Huang Z., Nishida J., Zhang L., Huang H. Signaling pathways that lead to the silencing of the interleukin-4-producing potential in Th1 cells. J Interfaces Cyt Resour 2009, 29:399-405.
17. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999, 17:593-623.
18. Lee J.S., Song C.H., Kim C.H., Kong S.J., Shon M.H., Jung S.S. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients. Med Microbiol Immunol 2003, 192:61-69.
19. Feng C.G., Jankovic D., Kullberg M., Cheever A., Scanga C.A., Hieny S. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 2003, 174:4185-4192.
20. Paliard X., de Waal Malefijt R., Yssel H., Blanchard D., Chretien I., Abrams J., de Vries J. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human;CD4+ and CD8+ T cell clones. J Immunol 2005, 141:849-855.
21. Flynn J.L., Goldstein M.M., Triebold K.J., Sypek J., Wolf S., Bloom B.R. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995, 155:2515-2524.
22. Flynn J.L., Chan J. Tuberculosis: Latency and reactivation. Infect Immun 2001, 69:4195-4201.
23. Sahiratmadja E., Baak-Pablo R., de Visser A., Alisjahbana B., Adnan I., van Crevel R., et al. Association of polymorphisms in IL-12/IFN-γ pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis 2009, 87:303-311.
24. Oswald I.P., Gazzinelli R.T., Sher A., James S.L. IL-10 synergizes with IL-4 and transforming growth factor-1 to inhibit macrophage cytotoxic activity. J Immunol 1992, 148:3578-3582.
25. Tsai W.C., Tsai J.J., Chen C.J., Yen J.H., Ou T.T., Liu H.W. Monocyte-derived cytokine-IL-12, TGF-beta 1 and TNF-alpha in patients with tuberculosis. J Med Sci 2002, 18:17-22.
26. Al-Attiyah R., Madi N.M., El-Shamy A.S., Wiker H.G., Andersen P., Mustafa A.S. Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 2006, 47:254-261.
27. Torres M., Herrera T., Villareal H., Rich E.A., Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998, 66:176-180.
28. Vankayalapati R., Wizel B., Weis S.E., Klucar P., Shams H., Samten B., Barnes P.F. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003, 36:24-28.
29. Schwander S.K., Torres M., Sada E., Carranza C., Ramos E., Tary-Lehmann M., et al. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 1998, 178:1434-1445.
30. Araujo Z., González N., de Cubeddu L., Ziegler R.C., de Waard J.H., Giampietro F., et al. Levels of complement C3 and C4 components in Amerindians living in an area with high prevalence of tuberculosis. Mem Inst Oswaldo Cruz 2006, 1:359-364.
31. Cooper P.J., Chico M.E., Sandoval C., Espinel I., Guevara A., Kennedy M.W., et al. Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis 2000, 182:1207-1213.
32. Resende Co T., Hirsch C.S., Toossi Z., Dietze R., Ribeiro-Rodrigues R. Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol 2007, 147:45-52.